Max Healthcare Institute Limited has informed the Exchange regarding Outcome of Board Meeting held on April 08, 2026.
MAXHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Max Healthcare's board approved two major items: (1) re-appointment of Mr. Narayan K. Seshadri as Non-Executive Non-Independent Director for 3 years (May 2026 to May 2029), subject to shareholder approval via postal ballot; and (2) acquisition of controlling stake (~58.39%) in Kalinga Hospital Ltd., a 250-bed NABH accredited multi-specialty hospital in Bhubaneswar, Odisha. The deal is valued at ₹300 crore (equity value including control premium) with KHL's FY25 revenue at ₹135.63 crore. To fund the acquisition, the Board approved External Commercial Borrowings of up to ₹300 crore from Standard Chartered Bank (SOFR + 165 bps, 5-year tenure). Additional commitments include a loan of up to ₹100 crore to KHL for facility revamp and a corporate guarantee of $5 million for refinancing existing promoter debt of KHL. The transaction is expected to close within 4-6 weeks.
The acquisition expands Max Healthcare's footprint into Eastern India through a well-established hospital with brownfield expansion potential (up to 1,000 beds on 10 acres). The ₹300 crore ECB financing is efficient but adds leverage. This is a positive strategic move that could boost revenue and beds immediately.